Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

Cited In for PubMed (Select 9624713)

1.

Comorbid Psychopathology and Alcohol Use Patterns among Methadone Maintenance Treatment Patients.

Moussas G, Fanouraki I, Pachi A, Asomatou A, Drylli O, Paschalakis G, Tselebis A, Giotakis K, Bratis D, Dermatis G, Malliori M.

J Addict. 2015;2015:197652. doi: 10.1155/2015/197652. Epub 2015 Mar 23.

2.

Measuring clinically significant outcomes - LDQ, CORE-10 and SSQ as dimension measures of addiction.

Raistrick D, Tober G, Sweetman J, Unsworth S, Crosby H, Evans T.

Psychiatr Bull (2014). 2014 Jun;38(3):112-5. doi: 10.1192/pb.bp.112.041301.

3.

Applying an ensemble classification tree approach to the prediction of completion of a 12-step facilitation intervention with stimulant abusers.

Doyle SR, Donovan DM.

Psychol Addict Behav. 2014 Dec;28(4):1127-43. doi: 10.1037/a0037235. Epub 2014 Aug 18.

PMID:
25134038
4.

Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users.

Nielsen S, Hillhouse M, Mooney L, Ang A, Ling W.

J Subst Abuse Treat. 2015 Jan;48(1):70-6. doi: 10.1016/j.jsat.2014.06.006. Epub 2014 Jun 28.

PMID:
25065489
5.

Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management?

Weiss RD, Griffin ML, Potter JS, Dodd DR, Dreifuss JA, Connery HS, Carroll KM.

Drug Alcohol Depend. 2014 Jul 1;140:118-22. doi: 10.1016/j.drugalcdep.2014.04.005. Epub 2014 Apr 24.

6.

Substance abuse, memory, and post-traumatic stress disorder.

Tipps ME, Raybuck JD, Lattal KM.

Neurobiol Learn Mem. 2014 Jul;112:87-100. doi: 10.1016/j.nlm.2013.12.002. Epub 2013 Dec 15. Review.

7.

Perceived stress and substance use in methadone-maintained smokers.

Moitra E, Anderson BJ, Stein MD.

Drug Alcohol Depend. 2013 Dec 1;133(2):785-8. doi: 10.1016/j.drugalcdep.2013.08.010. Epub 2013 Aug 26.

8.

Is it stress? The role of stress related systems in chronic food restriction-induced augmentation of heroin seeking in the rat.

Sedki F, Abbas Z, Angelis S, Martin J, D'Cunha T, Shalev U.

Front Neurosci. 2013 Jun 6;7:98. doi: 10.3389/fnins.2013.00098. eCollection 2013.

9.

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Scavone JL, Sterling RC, Van Bockstaele EJ.

Neuroscience. 2013 Sep 17;248:637-54. doi: 10.1016/j.neuroscience.2013.04.034. Epub 2013 Apr 24. Review.

10.

An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.

Crist RC, Clarke TK, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH.

Neuropsychopharmacology. 2013 Sep;38(10):2003-10. doi: 10.1038/npp.2013.99. Epub 2013 Apr 23. Erratum in: Neuropsychopharmacology. 2014 Mar;39(4):1039.

11.

A history of chronic morphine exposure during adolescence increases despair-like behaviour and strain-dependently promotes sociability in abstinent adult mice.

Lutz PE, Reiss D, Ouagazzal AM, Kieffer BL.

Behav Brain Res. 2013 Apr 15;243:44-52. doi: 10.1016/j.bbr.2012.12.049. Epub 2013 Jan 4.

12.

Does mandating offenders to treatment improve completion rates?

Coviello DM, Zanis DA, Wesnoski SA, Palman N, Gur A, Lynch KG, McKay JR.

J Subst Abuse Treat. 2013 Apr;44(4):417-25. doi: 10.1016/j.jsat.2012.10.003. Epub 2012 Nov 26.

13.

Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder.

Tamm L, Trello-Rishel K, Riggs P, Nakonezny PA, Acosta M, Bailey G, Winhusen T.

J Subst Abuse Treat. 2013 Feb;44(2):224-30. doi: 10.1016/j.jsat.2012.07.001. Epub 2012 Aug 11.

14.

Persistence on a stress-challenge task before initiating buprenorphine treatment was associated with successful transition from opioid use to early abstinence.

Strong DR, Brown RA, Sims M, Herman DS, Anderson BJ, Stein MD.

J Addict Med. 2012 Sep;6(3):219-25. doi: 10.1097/ADM.0b013e31825d927f.

15.

The social support and social network characteristics of smokers in methadone maintenance treatment.

de Dios MA, Stanton CA, Caviness CM, Niaura R, Stein M.

Am J Drug Alcohol Abuse. 2013 Jan;39(1):50-6. doi: 10.3109/00952990.2011.653424. Epub 2012 May 10.

16.

Superior methadone treatment outcome in Hmong compared with non-Hmong patients.

Bart G, Wang Q, Hodges JS, Nolan C, Carlson G.

J Subst Abuse Treat. 2012 Oct;43(3):269-75. doi: 10.1016/j.jsat.2011.12.006. Epub 2012 Jan 28.

17.

Substance abuse treatment client experience in an employed population: results of a client survey.

Merrick EL, Reif S, Hiatt D, Hodgkin D, Horgan CM, Ritter G.

Subst Abuse Treat Prev Policy. 2012 Jan 17;7:4. doi: 10.1186/1747-597X-7-4.

18.

Meta-analyses of seven of the National Institute on Drug Abuse's principles of drug addiction treatment.

Pearson FS, Prendergast ML, Podus D, Vazan P, Greenwell L, Hamilton Z.

J Subst Abuse Treat. 2012 Jul;43(1):1-11. doi: 10.1016/j.jsat.2011.10.005. Epub 2011 Nov 25.

19.

Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.

Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, Griffin ML, Gourevitch MN, Haller DL, Hasson AL, Huang Z, Jacobs P, Kosinski AS, Lindblad R, McCance-Katz EF, Provost SE, Selzer J, Somoza EC, Sonne SC, Ling W.

Arch Gen Psychiatry. 2011 Dec;68(12):1238-46. doi: 10.1001/archgenpsychiatry.2011.121. Epub 2011 Nov 7.

20.

Review of biological mechanisms and pharmacological treatments of comorbid PTSD and substance use disorder.

Norman SB, Myers US, Wilkins KC, Goldsmith AA, Hristova V, Huang Z, McCullough KC, Robinson SK.

Neuropharmacology. 2012 Feb;62(2):542-51. doi: 10.1016/j.neuropharm.2011.04.032. Epub 2011 May 13. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk